CurrentAetnaPolicy 0005

Septoplasty and Rhinoplasty

Clinical policy governing medical necessity, experimental/investigational and cosmetic coverage determinations for septoplasty and rhinoplasty for Aetna members.

Policy Summary

PayerAetna

PolicySeptoplasty and Rhinoplasty

Policy CodePolicy 0005

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

Key ActionDocument failure to respond to ≥4 weeks of appropriate medical therapy before septoplasty for nasal airway obstruction.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

4+ weeksconservative management interval

137RCT patients (bioabsorbable implant)

4.0-4.5%implant retrieval/migration

19trials in trans-septal suturing meta-analysis

0031related cosmetic policy

Coverage Criteria — Septoplasty & Rhinoplasty

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Evidence summaries (informational) — 1 top-level node

Evidence summaries (informational) — Select studies and reviews relevant to procedures considered in this policy.

threshold":""},{"text":"Septoplasty: randomized trial and reviews do not support routine systemic antibiotic prophylaxis or routine nasal packing after septoplasty. A large randomized trial (Ricci and D'Ascanio, 2012) found no benefit to routine antibiotics. Meta-analyses and systematic reviews (e.g., Banglawala et al, 2013; Gioacchini et al, 2014) found no benefit and potential increased complications and patient discomfort with routine nasal packing, and trans-septal suturing may reduce pain and adhesions compared with packing (systematic review/meta-analysis, Wang and Dong, 2017).","threshold":""},{"text":"Extracorporeal septoplasty: case series and technique reports support extracorporeal septoplasty as a surgical option for extreme septal deviations not amenable to intranasal approaches, with acceptable outcomes in selected patients; evidence is primarily case series/level IV. (See Fettman et al, Matulic & Skitarelic, Baumann).","threshold":""},{"text":"Ablation of septal swell bodies and pyriform aperture reduction (pyriform turbinoplasty): existing evidence consists mainly of small retrospective series, computational models, and preliminary reports with low levels of evidence; UpToDate reviews do not list these as standard therapeutic options. Larger, higher‑quality studies are needed to establish efficacy and safety."}]}

Coding — CPT/HCPCS/ICD-10

Septoplasty - Covered CPT Codes (if selection criteria met)CPTCovered

30520	Septoplasty or submucous resection, with or without cartilage scoring, contouring or replacement with graft.
30620	Septal or other intranasal dermatoplasty (does not include obtaining graft).

Other related CPT CodesCPT

30130	Excision inferior turbinate, partial or complete, any method.
30140	Submucous resection inferior turbinate, partial or complete, any method.
30465	Repair of nasal vestibular stenosis (eg, spreader grafting, lateral nasal wall reconstruction).
31231-31235	Nasal/sinus endoscopy, diagnostic.
31237-31294	Nasal/sinus endoscopy, surgical.

Rhinoplasty - Covered CPT Codes (limited circumstances / selection criteria)CPTCovered

30124	Excision dermoid cyst, nose; simple, skin, subcutaneous.
30125	Excision dermoid cyst, nose; complex, under bone or cartilage.
30420	Rhinoplasty, primary; including major septal repair.
30435	Rhinoplasty, secondary; intermediate revision (bony work with osteotomies).
30450	Major revision (bony work with osteotomies).
30460	Rhinoplasty for nasal deformity secondary to congenital cleft lip and/or palate, including columellar lengthening; tip only.
30462	Tip, septum, osteotomies.

CPT Codes Not Covered / Experimental for Indications ListedCPTNot Covered

30801	Ablation, soft tissue of inferior turbinates, unilateral or bilateral, any method (eg, electrocautery, radiofrequency ablation, or tissue volume reduction); superficial.
30802	Ablation, soft tissue of inferior turbinates, unilateral or bilateral, any method (eg, electrocautery, radiofrequency ablation, or tissue volume reduction); intramural (ie, submucosal).
0232T	Injection(s), platelet rich plasma, any site, including image guidance, harvesting and preparation when performed.
30400	Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip.
30410	Rhinoplasty, complete, external parts including bony pyramid, lateral and alar cartilages, and/or elevation of nasal tip.
30430	Rhinoplasty, secondary; minor revision (small amount of nasal tip work).

ICD-10 Codes (covered/mentioned)ICD-10

J32.0-J32.9	Chronic sinusitis
J34.2	Deviated nasal septum
J30.1-J30.9	Allergic rhinitis
R04.0	Epistaxis
Q35.1-Q35.9	Cleft palate
M95.0	Acquired deformity of nose

HCPCS / miscellaneous codes not coveredHCPCSNot Covered

G0460	Autologous platelet rich plasma for chronic wounds/ulcers (HCPCS) - listed as not covered for indications in CPB.
S9055	Procuren or other growth factor preparation to promote wound healing - listed as not covered.

No codes in this excerptmixed

No codes listed

Conservative management duration — >= 4 weeks

Required duration>= 4 weeks of appropriate medical therapy (e.g., nasal steroids or immunotherapy when appropriate)

PurposePrerequisite before considering many surgical interventions for nasal airway obstruction (septoplasty, rhinoplasty for vestibular stenosis)

DocumentationClinical record must document failure to respond to the >=4 weeks conservative management

Provider Actions — Authorization, Documentation & Denial Risks

Prior Authorization

Prior Authorization for Covered CPT Codes

Prior authorization is required for CPT codes listed as covered in this policy when the member meets the selection/medical necessity criteria in the policy (e.g., septoplasty CPT 30520, 30620 and listed rhinoplasty codes when the documented criteria are met). Prior authorization may also be required for operative combinations (septoplasty with turbinate reduction, implants) per plan administrative rules—check payer-specific authorization pathways.

Prior authorization required for covered CPT codes when selection criteria are met (see Applicable CPT codes section).
Verify authorization rules for combined procedures (e.g., septoplasty + ITR) and for outpatient vs. clinic-based procedures.

Prior Authorization

Prior Authorization for Novel / Limited‑Evidence Techniques

Novel, limited‑evidence, or emerging techniques (e.g., bioabsorbable lateral wall implants, extracorporeal septoplasty in select cases, Coblation NSB reduction, diced cartilage with blood products) should be prospectively reviewed. Submit detailed clinical rationale, prior conservative therapies, and relevant supporting literature when requesting authorization.

Prospective prior authorization recommended for novel or limited‑evidence techniques (e.g., Latera bioabsorbable implant, Coblation NSB reduction, balloon septoplasty, diced cartilage + blood products).
Include literature citation and risk/benefit discussion for innovative procedures; authorization may be denied if evidence is insufficient.

Denial Risk

Denial Triggers for Experimental / Not Covered Procedures

Procedures and techniques identified as experimental, investigational, or not covered (e.g., ablation of septal swell bodies for chronic rhinitis, balloon septoplasty, extracorporeal septoplasty for revision, absorbable nasal implants for indications beyond those supported by policy, pyriform aperture reduction) are denial triggers. Claims for these indications will be subject to denial unless an individual case review determines medical necessity.

Denial triggers include experimental/investigational procedures listed in the policy (see Experimental and Investigational section).
Balloon septoplasty and listed implant uses are examples that may be denied for routine coverage.

Note

Not Applicable / When Prior Authorization Is Unspecified

If content in this window does not specify a prior authorization requirement for a given procedure or device, follow standard plan prior authorization processes and consult payer-specific administrative guidance. Absence of an explicit authorization statement in these excerpts does not imply coverage; obtain pre-service review when in doubt.

No explicit prior authorization instruction in some study excerpts — verify plan administrative rules.
When policy text is silent about authorization for a procedure/device, submit a pre-service authorization request to avoid claim denials.

Denial Risk

Evidence Limitations That May Trigger Coverage Scrutiny

Be aware of evidence limitations that may prompt coverage scrutiny: short follow‑up, small single‑arm series, lack of randomized controls, and inconsistent long‑term outcomes. These limitations can lead to requests for additional documentation or denial pending further evidence.

Studies with short-term follow-up or single‑arm designs (e.g., early implant studies) may be insufficient for routine coverage decisions.
Payer may request long‑term outcomes, device retrieval/migration rates, and adverse event profiles before approving coverage.

Documentation Required

Required Documentation for Septoplasty Airway Indication

For septoplasty performed for nasal airway obstruction, document failure to respond to at least 4 weeks of appropriate conservative medical therapy (e.g., nasal steroids, immunotherapy where appropriate), and include specifics of prior treatments.

Document duration and details of medical therapy (medication names, doses, duration, response).
State reason conservative management was inadequate and dates of treatment.

Documentation Required

Diagnostic Evaluation Required

Diagnostic evaluation is required before surgical intervention. Provide symptom quantification, site and cause of obstruction, ENT exam findings, rhinoscopy/nasal endoscopy results, and any relevant history (trauma, congenital defects, disease).

History: duration, laterality, triggers, variability, prior trauma or surgeries.
Objective exam: ENT exam, rhinoscopy, flexible or rigid nasal endoscopy findings, and documentation of site/cause of obstruction.

Documentation Required

Imaging Documentation for Nasal Dermoid Surgery

Pre-operative imaging is essential for nasal dermoid evaluation and surgical planning. When intracranial extension is possible or suspected, include high‑resolution CT and/or MRI to document extent of lesion.

Obtain MRI thin‑section multiplanar imaging when intracranial extension is suspected.
CT and MRI findings should be included in the authorization and operative planning documentation.

Documentation Required

Suggested Clinical Documentation Elements

When submitting documentation for interventions (especially implants or novel devices), include baseline and follow‑up PROMs and objective measures where available (e.g., NOSE scores, VAS scores, LWI assessments), responder rates, adverse events, and duration of follow‑up to support effectiveness and safety.

Provide baseline NOSE and VAS scores and post‑treatment values with timelines.
Report responder status, adverse events, device retrievals/migration, and length of follow‑up (months/years).

Step Therapy

Conservative Therapy Prerequisite / First‑Line Management

Conservative medical management is the first‑line treatment for nasal obstruction and related conditions. Document trials of conservative therapy (e.g., nasal steroids, saline irrigations, allergy therapy) for at least 4 weeks prior to elective surgical procedures unless an exception is justified.

Conservative therapy prerequisite: ≥4 weeks of appropriate medical management (unless emergent indication).
Document specifics of medical therapy, patient adherence, and clinical response.

Step Therapy

Step Therapy — Not Described / Stepwise Management Context

This policy does not establish a formal step‑therapy protocol. There are no plan‑level step therapy sequences described in these excerpts; clinical sequencing (medical therapy → septoplasty → adjunctive ITR or implants) is described in background literature but not mandated as a formal step‑therapy requirement by the policy.

Step therapy not described in the policy text — do not infer a rigid step count beyond the documented conservative therapy prerequisite.
Clinical stepwise management context is provided (consider septoplasty before adjunctive procedures), but plan-level step therapy rules are absent.

Definitions & Key Terms

Septoplasty — Surgical correction of defects and deformities of the nasal septum by altering, splinting or removing obstructive tissue

DefinitionSurgical correction of defects and deformities of the nasal septum by altering, splinting, or removing obstructive tissue while maintaining or improving nasal physiological function.

Primary indicationsNasal airway obstruction due to septal deviation, recurrent epistaxis related to septal deformity, recurrent sinusitis when deviation contributes, or to gain surgical access.

Context noteSeptoplasty may be performed in association with cleft palate repair or after nasal trauma; asymptomatic septal deformity is not an indication unless it prevents access for other necessary intranasal procedures.

Reconstructive rhinoplasty — Surgery to correct external nasal deformity or replace lost tissue while maintaining or improving function

DefinitionSurgery of the nose to correct an external nasal deformity, damaged nasal structures or to replace lost tissue while maintaining or improving physiological function.

Covered circumstancesMedically necessary only for congenital cleft lip/palate deformity repair or removal of nasal dermoid; limited coverage for chronic non-septal airway obstruction (vestibular stenosis) when strict criteria are met.

DocumentationPre-operative photographs (4‑way) and evidence of prior conservative therapy and imaging/endoscopy required when performed for airway indications.

Nasal valves (internal and external) — Anatomical description of internal/external nasal valves and their role in airflow resistance

AnatomyNasal valves (vestibules) are areas just inside the nostrils comprised of cartilage that work together to keep the airway open by regulating airflow resistance.

Internal vs externalInternal valves are located at the upper edge of the hair-bearing area; external valves are at the edge of the nostril rim.

Clinical relevanceNarrowing, weakening, or collapse of the valves (nasal valve collapse/vestibular stenosis) can cause symptomatic nasal obstruction and may require targeted repair.

Extracorporeal septoplasty (ECS) — Resection, extracorporeal straightening, and re-implantation of the nasal septum for extreme deviations

DefinitionExtracorporeal septoplasty (ECS) entails resection, extracorporeal straightening, and re-implantation of the nasal septum to correct extreme septal deviations.

IndicationDescribed for initial correction of extremely deviated septum not correctable via intranasal approaches; Aetna considers ECS medically necessary for initial correction when septoplasty criteria are met.

LimitationsTechnique often used in conjunction with open septorhinoplasty for complex deformities; not recommended for routine cases or some revision scenarios.

Nasal valves (internal and external) — Nasal valve suspension (NVS) described

TechniqueNasal valve suspension (NVS) inserts a suture through the nasal mucosa into the valve and secures it to an orbital rim bone anchor to maintain valve patency.

PurposeProposed surgical treatment for nasal valve collapse to reduce airway obstruction by suspending the collapsed valve.

VariationsModifications include tunneled sutures to infra-orbital incisions and other suspension approaches reported in the literature.

Latera (absorbable nasal implant) — Polylactic acid copolymer bioabsorbable implant intended to support lateral nasal wall/cartilage

DeviceLatera is a polylactic acid copolymer bioabsorbable implant placed within the lateral nasal wall to support upper and lower lateral cartilage.

Intended effectDesigned to reinforce lateral nasal wall/cartilage and reduce nasal airway obstruction symptoms by supporting the nasal valve region.

Absorption timeframe and outcomesManufacturer states absorption over ~18 months; clinical studies report NOSE score improvements and implant retrieval/migration rates around 4% with follow-up up to 24 months.

Trans-septal suturing — Technique used instead of nasal packing after septoplasty to approximate mucoperichondrium and reduce post-op pain

TechniqueTrans-septal suturing approximates the septal mucoperichondrium after septoplasty as an alternative to nasal packing.

BenefitsMeta-analysis of 19 RCTs found trans-septal suturing associated with less post-operative pain, headache, and adhesions compared to nasal packing.

Safety profileSuturing and packing were equivalent for bleeding, hematoma, septal perforation, infection, and residual deviation in pooled analyses; further well-designed studies recommended.

Nasal dermoid with intracranial extension — Midline congenital nasal lesion requiring imaging to assess extent

DefinitionNasal dermoid is a midline congenital nasal lesion that may extend into bone or intracranially and can require imaging to assess extent.

ImagingHigh-resolution CT and/or MRI are essential pre-operatively to evaluate for intracranial extension and to guide surgical approach selection.

Surgical considerationsComplete excision with appropriate skull base repair is required for lesions with intracranial extension; approach (open, endoscopic, craniotomy) depends on extent.

NOSE score — Nasal Obstruction Symptom Evaluation, validated PROM

DefinitionNOSE score = Nasal Obstruction Symptom Evaluation, a validated patient-reported outcome measure to assess nasal obstruction severity and response to interventions.

Use in studiesReported as primary or secondary outcome in trials and cohorts evaluating nasal valve implants and surgical interventions, with responder definitions tied to NOSE change.

InterpretationResponder often defined as ≥1 NOSE category improvement or ≥20% reduction in NOSE score in randomized trials of implants.

Responder (as used in RCT) — Patient with reduction in clinical severity by ≥1 category or ≥20% reduction in NOSE score

DefinitionResponder = patient with reduction in clinical severity by ≥1 category or ≥20% reduction in NOSE score (as used in RCTs).

ContextUsed as the primary endpoint (responder rate) in the Latera randomized sham-controlled trial (Stolovitzky et al, 2019).

ApplicationResponder status used to compare treatment versus sham and to quantify clinical benefit in implant studies.

Epistaxis — Nosebleed

DefinitionEpistaxis = Nosebleed.

RelevanceRecurrent epistaxis related to septal deformity is listed as an indication for septoplasty.

Coding/assessmentDocument relationship of epistaxis to septal pathology when used to justify surgical intervention.

Pyriform aperture — Anterior opening of the nasal cavity in the skull

DefinitionPyriform aperture = Anterior opening of the nasal cavity in the skull.

Clinical notePyriform aperture anatomy is relevant to nasal airway and some described procedures (e.g., pyriform aperture reduction mentioned among investigational interventions).

Relation to policyPyriform aperture reduction is cited as not widely established and is listed among procedures of limited/uncertain evidence in the document.

Swell body — Widened region of the nasal septum located superior to the inferior turbinates and anterior to the middle turbinates

DefinitionSwell body = A widened region of the nasal septum located superior to the inferior turbinates and anterior to the middle turbinates.

Clinical relevanceSwell body may contribute to nasal obstruction; ablation of septal swell bodies is listed among procedures considered experimental/investigational.

ConsiderationAssessment should distinguish swell body-related obstruction from other anatomic causes when planning management.

OpenPayer

Septoplasty and Rhinoplasty

Coverage Criteria — Septoplasty & Rhinoplasty

Coding — CPT/HCPCS/ICD-10

Provider Actions — Authorization, Documentation & Denial Risks

Background & Clinical Context

Definitions & Key Terms

Policy Revision History